The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Early Degenerative Changes in Transgenic Mice Expressing Mutant Huntingtin Involve Dendritic Abnormalities but No Impairment of Mitochondrial Energy Production
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
West, M. J., Slomianka, L., & Gundersen, H. J. G. (1991) · The Anatomical Record · doi:10.1002/ar.1092310411 · Cited by 2,994
Pellerin, L., & Magistretti, P. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10625 · Cited by 2,927
New stereological methods for counting neurons
West, M. J. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90112-o · Cited by 940
Browne, S. E., Bowling, A. C., Macgarvey, U., Baik, M. J., Berger, S. C., Muquit, M. M. K., Bird, E. D., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410410514 · Cited by 885
Mitochondrial defect in Huntington's disease caudate nucleus
Gu, M., Gash, M. T., Mann, V. M., Javoy‐Agid, F., Cooper, J. M., & Schapira, A. H. V. (1996) · Annals of Neurology · doi:10.1002/ana.410390317 · Cited by 758
Energy metabolism defects in Huntington's disease and effects of coenzyme Q10
Koroshetz, W. J., Jenkins, B. G., Rosen, B. R., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410410206 · Cited by 405
Striatal glucose consumption in chorea-free subjects at risk of Huntington's disease
Kuwert, T., Boecker, H., Titz, H., Herzog, H., Wang, B. C., Nayak, U., Feinendegen, L. E., Lange, H. W., & Aulich, A. (1993) · Journal of Neurology · doi:10.1007/bf00870669 · Cited by 99
Research works printed but not linked: 67
- Ackrell, 1978, Mammalian succinate dehydrogenase, Methods Enzymol., 53, 466, 10.1016/S0076-6879(78)53050-4 · DOI · Paper page
- Alexi, 1998, Metabolic compromise with systemic 3-nitropropionic acid produces striatal apoptosis in Sprague–Dawley rats but not in BALB/c ByJ mice, Exp. Neurol., 153, 74, 10.1006/exnr.1998.6842 · DOI
- Andrade, 1995, HEAT repeats in the Huntington's disease protein, Nat. Genet., 11, 115, 10.1038/ng1095-115 · DOI · Paper page
- Antonini, 1996, Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease, Brain, 119, 2085, 10.1093/brain/119.6.2085 · DOI · Paper page
- Arenas, 1998, Complex I defect in muscle from patients with Huntington's disease, Ann. Neurol., 43, 397, 10.1002/ana.410430321 · DOI · Paper page
- Aronin, 1999, Are there multiple pathways in the pathogenesis of Huntington's disease?, Philos. Trans. R. Soc. London B, 354, 995, 10.1098/rstb.1999.0451 · DOI
- Beal, 1993, Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?, Trends Neurosci., 16, 125, 10.1016/0166-2236(93)90117-5 · DOI · Paper page
- Beal, 1998, Mitochondrial dysfunction in neurodegenerative diseases, Biochim. Biophys. Acta, 1366, 211, 10.1016/S0005-2728(98)00114-5 · DOI · Paper page
- Beal, 1993, Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid, J. Neurosci., 13, 4181, 10.1523/JNEUROSCI.13-10-04181.1993 · DOI · Paper page
- Beal, 1993, Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate, J. Neurochem., 61, 1147, 10.1111/j.1471-4159.1993.tb03633.x · DOI · Paper page
- Berent, 1988, Positron emission tomographic scan investigations of Huntington's disease: Cerebral metabolic correlates of cognitive function, Ann. Neurol., 23, 541, 10.1002/ana.410230603 · DOI · Paper page
- Bernard, 1998, Subcellular and subsynaptic distribution of the NR1 subunit of the NMDA receptor in the neostriatum and globus pallidus of the rat: Co-localization at synapses with the GluR2/3 subunit of the AMPA receptor, Eur. J. Neurosci., 10, 3721, 10.1046/j.1460-9568.1998.00380.x · DOI
- Bowling, 1995, Bioenergetic and oxidative stress in neurodegenerative diseases, Life Sci., 56, 1151, 10.1016/0024-3205(95)00055-B · DOI · Paper page
- Brennan, 1985, Regional mitochondrial respiratory activity in Huntington's disease brain, J. Neurochem., 44, 1948, 10.1111/j.1471-4159.1985.tb07192.x · DOI · Paper page
- Burke, 1996, Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH, Nat. Med., 2, 347, 10.1038/nm0396-347 · DOI · Paper page
- Ferrante, 1991, Proliferative and degenerative changes in striatal spiny neurons in Huntington's disease: A combined study using the section-Golgi method and calbindin D28k immunocytochemistry, J. Neurosci., 11, 3877, 10.1523/JNEUROSCI.11-12-03877.1991 · DOI · Paper page
- Gonzalez-Lima, 1991, Quantitative histochemistry of cytochrome oxidase in rat brain, Neurosci. Lett., 123, 251, 10.1016/0304-3940(91)90943-N · DOI
- Grafton, 1990, A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease, Ann. Neurol., 28, 614, 10.1002/ana.410280503 · DOI
- Grafton, 1992, Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington's disease, Arch. Neurol., 49, 1161, 10.1001/archneur.1992.00530350075022 · DOI · Paper page
- Graveland, 1985, Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease, Science, 227, 770, 10.1126/science.3155875 · DOI · Paper page
- Greene, 1995, Exacerbation of NMDA, AMPA, and l-glutamate excitotoxicity by the succinate dehydrogenase inhibitor malonate, J. Neurochem., 64, 2332, 10.1046/j.1471-4159.1995.64052332.x · DOI
- Greene, 1996, Bioenergetics and glutamate excitotoxicity, Prog. Neurobiol., 48, 613, 10.1016/0301-0082(96)00006-8 · DOI · Paper page
- Gutekunst, 1998, The cellular and subcellular localization of huntingtin-associated protein 1 (HAP1): Comparison with huntingtin in rat and human, J. Neurosci., 18, 7674, 10.1523/JNEUROSCI.18-19-07674.1998 · DOI · Paper page
- Halkjaer-Kristensen, 1979, Microphotometric analysis of NADH-tetrazolium reductase and alpha-glycerophosphate dehydrogenase in human quadriceps muscle, Histochem. J., 11, 127, 10.1007/BF01002990 · DOI
- Harris, 1999, Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease, Brain, 122, 1667, 10.1093/brain/122.9.1667 · DOI
- Hatefi, 1978, Preparation and properties of dihydroubiquinone: cytochrome c oxidoreductase (complex III), Methods Enzymol., 53, 35, 10.1016/S0076-6879(78)53010-3 · DOI
- Hatefi, 1978, Preparation and properties of NADH: Ubiquinone oxidoreductase (complex I), EC 1.6.5.3, Methods Enzymol., 53, 11, 10.1016/S0076-6879(78)53006-1 · DOI · Paper page
- Hess, 1953, Ultramicrospectrophotomeric determination of cytochrome oxidase for quantitative histochemistry, J. Biol. Chem., 204, 296, 10.1016/S0021-9258(18)66139-3 · doi:10.1016/s0021-9258(18)66139-3
- Hyrc, 1997, Ionized intracellular calcium concentration predicts excitotoxic neuronal death: Observations with low-affinity fluorescenct calcium indicators, J. Neurosci., 17, 6669, 10.1523/JNEUROSCI.17-17-06669.1997 · DOI · Paper page
- Izumi, 1997, Endogenous monocarboxylates sustain hippocampal synaptic function and morphological integrity during energy deprivation, J. Neurosci., 17, 9448, 10.1523/JNEUROSCI.17-24-09448.1997 · DOI · Paper page
- Jenkins, 1996, Non-invasive neurochemical analysis of focal excitotoxic lesions in models of neurodegenerative illness using spectroscopic imaging, J. Cereb. Blood Flow Metab., 16, 450, 10.1097/00004647-199605000-00011 · DOI
- Jenkins, 1993, Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy, Neurology, 43, 2689, 10.1212/WNL.43.12.2689 · DOI · Paper page
- Jenkins, 1998, 1H NMR spectroscopy studies of Huntington's disease: Correlations with CAG repeat numbers, Neurology, 50, 1357, 10.1212/WNL.50.5.1357 · DOI · Paper page
- Kieburtz, 1999, Antiglutamate therapies in Huntington's disease, J. Neural Transm. Suppl., 55, 97
- Klivenyi, 1999, Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis, Nat. Med., 5, 347, 10.1038/6568 · DOI · Paper page
- Kuppenbender, 2000, Expression of NMDA receptor subunit mRNAs in neurochemically identified projection and interneurons in the human striatum, J. Comp. Neurol., 419, 407, 10.1002/(SICI)1096-9861(20000417)419:4<407::AID-CNE1>3.0.CO;2-I · DOI
- Landas, 1982, Staining of human and rat brain Vibratome sections by a new Golgi method, J. Neurosci. Methods, 5, 147, 10.1016/0165-0270(82)90061-9 · doi:10.1016/0165-0270(82)90061-9
- Li, 1993, Huntington's disease gene (IT15) is widely expressed in human and rat tissues, Neuron, 11, 985, 10.1016/0896-6273(93)90127-D · DOI · Paper page
- Li, 1995, A huntingtin-associated protein enriched in brain with implications for pathology, Nature, 378, 398, 10.1038/378398a0 · DOI · Paper page
- Lipton, 1991, Calcium channel antagonists in the prevention of neurotoxicity, Adv. Pharmacol., 22, 271, 10.1016/S1054-3589(08)60038-1 · DOI
- Maus, 1999, Pyruvate and lactate protect striatal neurons against N-methyl-D-aspartate-induced neurotoxicity, Eur. J. Neurosci., 11, 3215, 10.1046/j.1460-9568.1999.00745.x · DOI
- Mazziotta, 1987, Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease, N. Engl. J. Med., 316, 357, 10.1056/NEJM198702123160701 · DOI · Paper page
- Ona, 1999, Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease, Nature, 399, 263, 10.1038/20446 · DOI · Paper page
- Page, 1998, The expression of Huntingtin-associated protein (HAP1) mRNA in developing, adult and ageing rat CNS: Implications for Huntington's disease neuropathology, Eur. J. Neurosci., 10, 1835, 10.1046/j.1460-9568.1998.00185.x · DOI
- Parker, 1990, Evidence for a defect in NADH: Ubiquinone oxidoreductase (complex I) in Huntington's disease, Neurology, 40, 1231, 10.1212/WNL.40.8.1231 · DOI · Paper page
- Patel, 1996, Requirement for superoxide in excitotoxic cell death, Neuron, 16, 345, 10.1016/S0896-6273(00)80052-5 · DOI · Paper page
- Poeggeler, 1998, Dopaminergic control of kynurenate levels and N-methyl-D-aspartate toxicity in the developing rat striatum, Dev. Neurosci., 20, 146, 10.1159/000017309 · DOI
- Reddy, 1999, Transgenic mice expressing mutated full-length HD cDNA: A paradigm for locomotor changes and selective neuronal loss in Huntington's disease, Philos Trans. R. Soc. London B, 354, 1035, 10.1098/rstb.1999.0456 · DOI
- Reddy, 1998, Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA, Nat. Genet., 20, 198, 10.1038/2510 · DOI · Paper page
- Reddy, 1999, Recent advances in understanding the pathogenesis of Huntington's disease, Trends Neurosci., 22, 248, 10.1016/S0166-2236(99)01415-0 · DOI · Paper page
- Sanchez-Pernaute, 1999, Clinical correlation of striatal 1H MRS changes in Huntington's disease, Neurology, 53, 806, 10.1212/WNL.53.4.806 · DOI
- Sawa, 1999, Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization, Nat. Med., 5, 1194, 10.1038/13518 · DOI · Paper page
- Schapira, 1998, Mitochondrial dysfunction in neurodegenerative disorders, Biochim. Biophys. Acta, 1366, 225, 10.1016/S0005-2728(98)00115-7 · DOI · Paper page
- Schurr, 1999, An increase in lactate output by brain tissue serves to meet the energy needs of glutamate-activated neurons, J. Neurosci., 19, 34, 10.1523/JNEUROSCI.19-01-00034.1999 · DOI · Paper page
- Schurr, 1997, Glia are the main source of lactate utilized by neurons for recovery of function posthypoxia, Brain Res., 4, 221, 10.1016/S0006-8993(97)81708-8 · DOI
- Schwarcz, 1983, Quinolinic acid: An endogenous metabolite that produces axon-sparing lesions in rat brain, Science, 219, 316, 10.1126/science.6849138 · DOI · Paper page
- Sharp, 1995, Widespread expression of Huntington's disease gene (IT15) protein product, Neuron, 14, 1065, 10.1016/0896-6273(95)90345-3 · DOI · Paper page
- Soltanpour, 1996, Neurons and microvessels of the nodose (vagal sensory) ganglion in young adult and aged rats: Morphometric and enzyme histochemical studies, Tissue Cell, 28, 593, 10.1016/S0040-8166(96)80062-0 · doi:10.1016/s0040-8166(96)80062-0
- Strong, 1993, Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues, Nat. Genet., 5, 259, 10.1038/ng1193-259 · DOI · Paper page
- Tabrizi, 1999, Biochemical abnormalities and excitotoxicity in Huntington's disease brain, Ann. Neurol., 45, 25, 10.1002/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E · doi:10.1002/1531-8249(199901)45:1<25::aid-art6>3.0.co;2-e
- Tabrizi, 2000, Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse, Ann. Neurol., 47, 80, 10.1002/1531-8249(200001)47:1<80::AID-ANA13>3.0.CO;2-K · DOI · Paper page
- Tsacopoulos, 1996, Metabolic coupling between glia and neurons, Neurosci. Lett., 16, 877
- Valdes, 1993, A simple non-radioactive method for diagnosis of Huntington's disease, Hum. Mol. Genet., 2, 633, 10.1093/hmg/2.6.633 · DOI
- Vonsattel, 1985, Neuropathological classification of Huntington's disease, J. Neuropathol. Exp. Neurol., 44, 559, 10.1097/00005072-198511000-00003 · DOI · Paper page
- Wong-Riley, 1989, Cytochrome oxidase: an endogenous metabolic marker for neuronal activity, Trends Neurosci., 12, 94, 10.1016/0166-2236(89)90165-3 · DOI · Paper page
- Zeevalk, 1991, Mechanisms underlying initiation of excitotoxicity associated with metabolic inhibition, J. Pharmacol. Exp. Ther., 257, 870
- Zeevalk, 1993, Hypothermia, metabolic stress, and NMDA-mediated excitotoxicity, J. Neurochem., 61, 1153, 10.1111/j.1471-4159.1993.tb13639.x · doi:10.1111/j.1471-4159.1993.tb13639.x
Cited by
Coupling endoplasmic reticulum stress to the cell death program
Rao, R. V., Ellerby, H. M., & Bredesen, D. E. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401378 · Cited by 1,209
Dendritic Spine Pathology: Cause or Consequence of Neurological Disorders?
Fiala, J. C., Spacek, J., & Harris, K. M. (2002) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00158-3 · Cited by 811
Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases
Trushina, E., & McMurray, C. T. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.10.056 · Cited by 439
Misfolded proteins, endoplasmic reticulum stress and neurodegeneration
Rao, R. V., & Bredesen, D. E. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.09.012 · Cited by 430
Baquet, Z. C., Gorski, J. A., & Jones, K. R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3920-03.2004 · Cited by 414
Metadata
- Authors
- Guidetti, P., Charles, V., Chen, E.-Y., Reddy, P. H., Kordower, J. H., Whetsell, W. O., Schwarcz, R., & Tagle, D. A.
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2001-06
- Volume
- 169
- Issue
- 2
- Pages
- 340-350
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W2022863516
- Cited by
- 198
- References
- 8
- FWCI
- 4.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Early Degenerative Changes in Transgenic Mice Expressing Mutant Huntingtin Involve Dendritic Abnormalities but No Impairment of Mitochondrial Energy Production. https://app.cochat.ai/papers/10.1006/exnr.2000.7626
- The paper
- Guidetti, P., Charles, V., Chen, E.-Y., Reddy, P. H., Kordower, J. H., Whetsell, W. O., Schwarcz, R., & Tagle, D. A. (2001). Early Degenerative Changes in Transgenic Mice Expressing Mutant Huntingtin Involve Dendritic Abnormalities but No Impairment of Mitochondrial Energy Production. Experimental Neurology. https://doi.org/10.1006/exnr.2000.7626
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.